Lung Cancer Clinical Trial
Official title:
Computerized Scheduling of Nicotine Inhaler Use
RATIONALE: Computer-assisted scheduling of nicotine inhaler use may be an effective method
to help people stop smoking.
PURPOSE: Randomized cinical trial to compare the effectiveness of computer-assisted
scheduling of nicotine inhaler use with that of self-scheduled nicotine inhaler use in
participants who plan to stop smoking.
OBJECTIVES: I. Determine the effect of program length on inhaler use compliance, latency to
smoking relapse, and gradual cessation of inhaler use in participants using a
computer-assisted program to schedule nicotine inhaler dosing for smoking cessation. II.
Compare fast and slow paced versions of computer-assisted scheduling of nicotine inhaler use
versus ad libitum nicotine inhaler use, in terms of smoking cessation rates, in these
participants. III. Compare these dosing conditions, in terms of adherence, initial dosing
levels, and successful tapering effects, in these participants.
OUTLINE: This is a randomized study. Participants are randomized to one of three arms. All
participants monitor their period of cigarette smoking for 7 days by pressing a data input
button on a hand-held computer every time they smoke. Arm I: Participants begin using a
nicotine inhaler according to the dosing instructions that come with it and monitor their
inhaler usage with the hand-held computer. Arm II: Participants are prompted by the
hand-held computer to use a nicotine inhaler based on their prior smoking habits. When
prompted, participants use the nicotine inhaler at a comfortable rate over 20 minutes. The
computer prompts participants at a fixed frequency and duration of inhaler use for 3 weeks
and then tapers the frequency and duration over 3-5 weeks. Arm III: Participants are
prompted by the hand-held computer and use a nicotine inhaler as in arm II. The computer
prompts participants at a fixed frequency and duration of inhaler use for 12 weeks and then
tapers the frequency and duration over 3-5 weeks. Participants keep a weekly diary of the
average number of cigarettes smoked, average number of inhaler sessions, and average length
of each session. Participants also record the date of any 24-hour smoking cessation and
relapse and complete a withdrawal symptoms questionnaire. Participants are followed at 1
year.
PROJECTED ACCRUAL: A total of 480 participants will be accrued for this study.
;
Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|